Lopinavir, 98%, Thermo Scientific Chemicals

Name: Lopinavir, 98&percnt;, Thermo Scientific Chemicals
SKU: 456750010

Lopinavir, CAS # 192725-17-0, is an antiretroviral drug of the amphetamine class.

變更視圖

產品號碼	Quantity
456750010	1g
456750050	5g

2 選項

嘗試 chem dex^TM 網路應用程式

This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.

產品號碼 456750010

價格 (TWD)

Quantity:

Request bulk or custom format

化學識別

CAS192725-17-0

IUPAC Name(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide

Molecular FormulaC37H48N4O5

InChI KeyKJHKTHWMRKYKJE-SUGCFTRWSA-N

SMILESCC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)COC1=C(C)C=CC=C1C)CC1=CC=CC=C1

檢視更多

規格

規格表

Appearance (Color)White to beige

Water=<4 %

HPLC>=97.5 %

Specific optical rotation(On anhydrous substance)

Appearance (Form)Powder

檢視更多

This Thermo Scientific Chemicals brand product was originally part of the Acros Organics product portfolio. Some documentation and label information may refer to the legacy brand. The original Acros Organics product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

General Description

• Lopinavir is a retroviral protease inhibitor that acts as an antiretroviral and can prevent the propagation of human immunodeficiency virus (HIV) and hepatitis viruses within cells

• Lopinavir is a dicarboxylic acid diamide and a substituted form of amphetamine

Applications

• Lopinavir may be used in the laboratory study of other retroviruses

• Lopinavir is suitable for laboratory research of drug delivery systems; some studies have shown that the activity of lopinavir can be enhanced by alternative delivery methods such as microencapsulation

RUO – Research Use Only

Literature References

Hosseini, F.S.; Malektojari, A.; Ghazizadeh, S.; Hassaniazad, M.; Davoodian, P.; Dadvand, H.; Nikpoor, A.R.; Nikoofal-Sahlabadi, S.; Kahoori, S.; Sepandi, M.; Hassanipour, S.; Fathalipour, M. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2021, 22(1),4. Ansari, H.; Singh, P. Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV. Curr HIV Res. 2018, 16(4), 270-279.